Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study
-
Published:2024-09
Issue:
Volume:
Page:
-
ISSN:1538-7836
-
Container-title:Journal of Thrombosis and Haemostasis
-
language:en
-
Short-container-title:Journal of Thrombosis and Haemostasis
Author:
Kraler SimonORCID, Liberale Luca, Nopp Stephan, Englisch Cornelia, Grilz Ella, Lapikova-Bryhinska Tetiana, Akhmedov Alexander, Carbone Federico, Ramoni Davide, Tirandi Amedeo, Scuricini Alessandro, Isoppo Simone, Tortorella Curzia, La Rosa Federica, Michelauz Cristina, Frè Federica, Gavoci Aurora, Lisa Anna, Suter Thomas M., von Eckardstein Arnold, Wenzl Florian A., Pabinger Ingrid, Lüscher Thomas F., Montecucco Fabrizio, Ay CihanORCID, Moik FlorianORCID
Reference55 articles.
1. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 Study;Roth;J Am Coll Cardiol,2020 2. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019;Kocarnik;JAMA Oncol,2022 3. Does cardiovascular mortality overtake cancer mortality during cancer survivorship?: an English retrospective cohort study;Strongman;JACC CardioOncol,2022 4. Incident cardiovascular disease among adults with cancer: a population-based cohort study;Paterson;JACC CardioOncol,2022 5. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS);Lyon;Eur Heart J,2022
|
|